Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: The CASA randomized trial
Open Access
- 1 April 2013
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 22 (2) , 130-137
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Detecting Disabilities in Older Patients With Cancer: Comparison Between Comprehensive Geriatric Assessment and Vulnerable Elders Survey-13Journal of Clinical Oncology, 2010
- Metronomic administration of pegylated liposomal-doxorubicin in extensively pre-treated metastatic breast cancer patients: A mono-institutional case-series reportThe Breast, 2010
- Adjuvant Chemotherapy in Older Women with Early-Stage Breast CancerNew England Journal of Medicine, 2009
- Breast Cancer in the ElderlyJournal of Clinical Oncology, 2007
- Anthracyclines, Mitoxantrone, Radiotherapy, and Granulocyte Colony-Stimulating Factor: Risk Factors for Leukemia and Myelodysplastic Syndrome After Breast CancerJournal of Clinical Oncology, 2007
- Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast CancerJAMA, 2006
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- The anti-angiogenic basis of metronomic chemotherapyNature Reviews Cancer, 2004
- Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levelsAnnals of Oncology, 2002
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958